These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18069451)

  • 21. Serum proteomics of glioma: methods and applications.
    Somasundaram K; Nijaguna MB; Kumar DM
    Expert Rev Mol Diagn; 2009 Oct; 9(7):695-707. PubMed ID: 19817554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for cardiovascular disease: challenges and future directions.
    May A; Wang TJ
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent progress of proteomics in critical illness.
    Karvunidis T; Mares J; Thongboonkerd V; Matejovic M
    Shock; 2009 Jun; 31(6):545-52. PubMed ID: 19106823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HP-Lattice QSAR for dynein proteins: experimental proteomics (2D-electrophoresis, mass spectrometry) and theoretic study of a Leishmania infantum sequence.
    Dea-Ayuela MA; Pérez-Castillo Y; Meneses-Marcel A; Ubeira FM; Bolas-Fernández F; Chou KC; González-Díaz H
    Bioorg Med Chem; 2008 Aug; 16(16):7770-6. PubMed ID: 18662882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics: a new approach to the study of disease.
    Chambers G; Lawrie L; Cash P; Murray GI
    J Pathol; 2000 Nov; 192(3):280-8. PubMed ID: 11054709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular diseases as target for imaging.
    Graf K; Gräfe M; Fleck E
    Basic Res Cardiol; 2008 Mar; 103(2):82-6. PubMed ID: 18324363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodality nanotracers for cardiovascular applications.
    Mulder WJ; Cormode DP; Hak S; Lobatto ME; Silvera S; Fayad ZA
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S103-11. PubMed ID: 18641599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and proteomic applications in diagnosis of platelet disorders and classification.
    Senzel L; Gnatenko DV; Bahou WF
    Semin Thromb Hemost; 2008 Sep; 34(6):532-8. PubMed ID: 19085652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage proteomics: applications of mass spectrometry.
    Lavigne R; Ceyssens PJ; Robben J
    Methods Mol Biol; 2009; 502():239-51. PubMed ID: 19082560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing and evaluating genomics- or proteomics-based diagnostic tests: statistical perspectives.
    Peng X
    Methods Mol Med; 2006; 129():27-39. PubMed ID: 17085803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue imaging using MALDI-MS: a new frontier of histopathology proteomics.
    Fournier I; Wisztorski M; Salzet M
    Expert Rev Proteomics; 2008 Jun; 5(3):413-24. PubMed ID: 18532909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic investigation of the hemolymph proteome of Manduca sexta at the fifth instar larvae stage using one- and two-dimensional proteomics platforms.
    Furusawa T; Rakwal R; Nam HW; Hirano M; Shibato J; Kim YS; Ogawa Y; Yoshida Y; Kramer KJ; Kouzuma Y; Agrawal GK; Yonekura M
    J Proteome Res; 2008 Mar; 7(3):938-59. PubMed ID: 18198843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic profiling of beta-cells using a classical approach - two-dimensional gel electrophoresis.
    Süss C; Solimena M
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S13-20. PubMed ID: 18777447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives for imaging mass spectrometry in the proteomics landscape.
    MacAleese L; Stauber J; Heeren RM
    Proteomics; 2009 Feb; 9(4):819-34. PubMed ID: 19212956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular imaging: a primer for interventionalists and imagers.
    Wang DS; Dake MD; Park JM; Kuo MD
    J Vasc Interv Radiol; 2006 Sep; 17(9):1405-23. PubMed ID: 16990461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research.
    Hirano M; Rakwal R; Shibato J; Sawa H; Nagashima K; Ogawa Y; Yoshida Y; Iwahashi H; Niki E; Masuo Y
    J Proteome Res; 2008 Jun; 7(6):2471-89. PubMed ID: 18457438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.